The company reported standalone net profit of Rs 724.81 crore for the quarter ended September 30, 2020 as compared to Rs 823.16 crore in the same period last year, regist..
Below is the Quote on Sun Pharma Ltd By Mr. Yash Gupta- Equity Research Associate, Angel Broking Ltd
“Sun Pharma Advanced Research Company L..
Sun Pharmaceutical Industries Ltd invested around Rs 2,000 crore in research and development (R&D) in the last financial year (2019-20).
In his message to the shar..
Strong margin beat but US sales plunge
* Sharp cut in opex, lower R&D spends and rise in gross margins boosted EBITDA margins by 765bps qoq to 24.3%. These trends..
Operationally strong performance
Sun Pharmaceutical Industries’ (Sun) reported strong operational performance in Q1FY21 beat our estimate of gross and EBITDA ma..
US drags down revenues but margins improve…
Revenues de-grew 9.4% YoY to | 7585 crore (I-direct estimate: | 7948 crore) mainly due to 27.5% YoY decline in US f..
Below is the Quote on Sun Pharma Mr. Yash Gupta - Equity Research Associate, Angel Broking Ltd
Sun Pharmaceutical industry Ltd. which has the highest market share..
COVID-19 impacts sales in EMs/US/ROW
Margins remain steady despite decline in most business segments
* The COVID-19 pandemic impacted YoY sales growth across marke..
Sun Pharma (SUNPHA): Faster retracement followed by multi year down trend line spells structural turnaround
* The pharma sector witnessed a structural turnaround in th..
Momentum Pick - Buy Sun Pharmaceutical Industries Ltd For Target Rs. 548 - HDFC Securities
After showing a minor declines/sideways consolidation, ..
Taro’s resolution with DOJ removes key overhang
Sun Pharma’s (Sun) subsidiary, Taro Pharma, has resolved all the cases adhering to the multi-year investig..
Sun Pharmaceuticals is the largest Indian pharma company with 8.2% market share in IPM (Indian Pharmaceutical Market). Company is ranked no.1 in India while..
Rupee falls 10 paise to 73.94 against US dollar in early trade
Rate decision, US stimulus likely constraints to rupee's further appreciation
NCLT approves sale of IL&FS education arm to LEHL
Hyundai Motor India adds new Board members
Vodafone Idea board to mull raising funds post AGR verdict
NCDEX Turmeric Future price has traded bearish during the month of November - Choice Broking
MCX Aluminium futures traded mixed to bullish during the month of November - Choice Broking
13000 finally a reality, banking propels the move By Sameet Chavan, Angel Broking
Buy Crude Oil Above 3250 SL BELOW 3200 TGT 3320/3350 - Axis Securities
© Copyright 2017 - investmentguruindia | All Rights Reserved. | Crafted By - Digi Interface